SBC Medical Group Holdings Incorporated
SBCIndustrialsNASDAQConsulting Services
Scan Results
Daily timeframeSBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. With a market capitalization of $440.2M, it sits in small-cap territory. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement.
Market Cap
$440.2M
Beta
0.59
P/E (TTM)
8.92
P/E (Fwd)
7.93
EPS (TTM)
$0.48
EPS (Fwd)
$0.54
ROE
18.9%
ROA
11.3%
Cash
$184.6M
Total Debt
$48.2M
Free CF
$63.2M
52W Change
1.9%
Annual Financials
Cash vs Debt
Where SBC stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, SBC finished 18.16% above its 150-day moving average ($3.58) and 14.32% above its 200-day moving average ($3.70). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SBC overbought or oversold?
At the September 3, 2026 close, SBC's RSI(14) was 76.0, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
SBC Medical Group Holdings Incorporated holds $184.6M in cash against $48.2M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $63.2M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 18.9% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 11.3% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $174.2M (2022) to $173.6M (2025).
With a beta below 0.7, SBC Medical Group Holdings Incorporated typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. With cash comfortably exceeding debt, SBC has financial flexibility that may help navigate uncertain periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SBC.